Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery

Du Toit, 2020, Outbreak of a novel coronavirus, Nat Rev Microbiol, 18, 10.1038/s41579-020-0332-0

Lu, 2020, Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle, J Med Virol, 92, 401, 10.1002/jmv.25678

Hui, 2020, The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China, Int J Infect Dis, 91, 264, 10.1016/j.ijid.2020.01.009

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8

World Health Organization

Zhao, 2020, Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak, Int J Infect Dis, 92, 214, 10.1016/j.ijid.2020.01.050

Lai, 2020, Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status, Int J Antimicrob Agents, 55, 105946, 10.1016/j.ijantimicag.2020.105946

Johnson, 2020, Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020, Euro Surveill, 25, 10.2807/1560-7917.ES.2020.25.9.2000202

Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3

Chen, 2020, Emerging coronaviruses: Genome structure, replication, and pathogenesis, J Med Virol, 92, 418, 10.1002/jmv.25681

Peiris, 2004, Severe acute respiratory syndrome, Nat Med, 10, S88, 10.1038/nm1143

Zaki, 2012, Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia, N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7

Donoghue, 2000, A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9, Circ Res, 87, 10.1161/01.RES.87.5.e1

Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145

Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury, Nat Med, 11, 875, 10.1038/nm1267

Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y

Gallagher, 2001, Coronavirus Spike Proteins in Viral Entry and Pathogenesis, Virology, 279, 371, 10.1006/viro.2000.0757

Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507

Hoffmann, 2020, The Novel Coronavirus 2019 (2019-NCoV) Uses the SARS-Coronavirus Receptor ACE2 and the Cellular Protease TMPRSS2 for Entry into Target Cells, Mol Biol, 181, 271

Matsuyama, 2020, Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells, Proc Natl Acad Sci Unit States Am, 117, 7001, 10.1073/pnas.2002589117

Ou, 2020, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat Commun, 11, 1620, 10.1038/s41467-020-15562-9

Shereen, 2020, COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, J Adv Res, 24, 91

Verdecchia, 2020, The pivotal link between ACE2 deficiency and SARS-CoV-2 infection, Eur J Intern Med, 76, 14, 10.1016/j.ejim.2020.04.037

Spiteri, 2020, First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020, Euro Surveill, 25, 10.2807/1560-7917.ES.2020.25.9.2000178

2020

Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, 20, 533, 10.1016/S1473-3099(20)30120-1

Onder, 2020, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, J Am Med Assoc, 323, 1775

World Health Organization, 2020

2020

Cui, 2019, Origin and evolution of pathogenic coronaviruses, Nat Rev Microbiol, 17, 181, 10.1038/s41579-018-0118-9

Li, 2005, Bats Are Natural Reservoirs of SARS-Like Coronaviruses, Science, 310, 676, 10.1126/science.1118391

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

To, 2020, Consistent Detection of 2019 Novel Coronavirus in Saliva, Clin Infect Dis, 10.1093/cid/ciaa149

Li, 2020, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia, N Engl J Med, 382, 1199, 10.1056/NEJMoa2001316

Backer, 2020, Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020, Euro Surveill, 25, 10.2807/1560-7917.ES.2020.25.5.2000062

Qiu, 2020, Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China, J Med Virol, 10.1002/jmv.25975

Ong SWX, Tan YK, Chia PY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. Published online March 4, 2020. Accessed 11.04.2020.

Yeo, 2020, Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?, Lancet Gastroenterol Hepatol, 5, 335, 10.1016/S2468-1253(20)30048-0

Zou, 2020, SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, N Engl J Med, 382, 1177, 10.1056/NEJMc2001737

Rothe, 2020, Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, N Engl J Med, 382, 970, 10.1056/NEJMc2001468

Pan, 2020, Asymptomatic cases in a family cluster with SARS-CoV-2 infection, Lancet Infect Dis, 20, 410, 10.1016/S1473-3099(20)30114-6

Shi, 2020, Susceptibility of Ferrets, Cats, Dogs, and Different Domestic Animals to SARS-Coronavirus-2, Microbiology, 368, 1016

Leroy, 2020, The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic, One Health, 13, 100133, 10.1016/j.onehlt.2020.100133

World Health Organization, 2020

Liu, 2020, The reproductive number of COVID-19 is higher compared to SARS coronavirus, J Trav Med, 27, 10.1093/jtm/taaa021

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Sama, 2020, Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors, Eur Heart J, 41, 1810, 10.1093/eurheartj/ehaa373

Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. Published online March 13, 2020. Accessed 18.04.2020

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x

Wang, 2020, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China, J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5

Shi, 2020, Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China, JAMA Cardiol, 25

Guo, 2020, Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19), JAMA Cardiol, 27

Chen, 2020, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, 26, m1091, 10.1136/bmj.m1091

Hu, 2020, Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin, Eur Heart J, 16, ehaa190

Zeng, 2020, First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights, Infection, 10, 1

Inciardi, 2020, Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19), JAMA Cardiol, 10.1001/jamacardio.2020.1096

Doyen, 2020, Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes, Lancet, 9, 1516, 10.1016/S0140-6736(20)30912-0

Thygesen, 2019, Fourth universal definition of myocardial infarction (2018), Eur Heart J, 40, 237, 10.1093/eurheartj/ehy462

Bonow, 2020, Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality, JAMA Cardiol, 10.1001/jamacardio.2020.1105

Gembardt, 2005, Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents, Peptides, 26, 1270, 10.1016/j.peptides.2005.01.009

Chen, 2020, The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2, Cardiovasc Res, 1, 1097, 10.1093/cvr/cvaa078

Monteil, 2020, Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2, Cell, 181, 905, 10.1016/j.cell.2020.04.004

Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5

Fung, 2016, Myocarditis. Circ Res., 118, 496, 10.1161/CIRCRESAHA.115.306573

Merad, 2020, Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages, Nat Rev Immunol, 20, 355, 10.1038/s41577-020-0331-4

Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis

Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 8, 420, 10.1016/S2213-2600(20)30076-X

Hansson, 2015, Inflammation and plaque vulnerability, J Intern Med, 278, 483, 10.1111/joim.12406

Libby, 2020, The Heart in COVID19: Primary Target or Secondary Bystander?, JACC Basic Transl Sci, 10, 537, 10.1016/j.jacbts.2020.04.001

Xu, 2020, Effective treatment of severe COVID-19 patients with tocilizumab, Proc Natl Acad Sci U S A, 19, 10970, 10.1073/pnas.2005615117

Choy, 2020, Translating IL-6 biology into effective treatments, Nat Rev Rheumatol, 16, 335, 10.1038/s41584-020-0419-z

Dong, 2020, Epidemiology of COVID-19 Among Children in China, Pediatrics, 145, 10.1542/peds.2020-0702

Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X

Wang, 2015, Macrophage activation syndrome in Kawasaki Disease: More common than we thought?, Semin Arthritis Rheum, 44, 405, 10.1016/j.semarthrit.2014.07.007

Viner, 2020, Kawasaki-like disease: emerging complication during the COVID-19 pandemic, Lancet, 395, 1741, 10.1016/S0140-6736(20)31129-6

Guan, 2020, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032

Huang, 2020, Clinical Findings of Patients with Coronavirus Disease 2019 in Jiangsu Province, China: A Retrospective, Multi-Center Study, PLoS Negl Trop Dis, 14, 10.1371/journal.pntd.0008280

Han, 2020, Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China, J Med Virol, 92, 819, 10.1002/jmv.25809

Rodriguez-Morales, 2020, Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Trav Med Infect Dis, 34, 101623, 10.1016/j.tmaid.2020.101623

Li, 2020, The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia, Invest Radiol, 55, 327, 10.1097/RLI.0000000000000672

Eltzschig, 2011, Hypoxia and Inflammation, N Engl J Med, 364, 656, 10.1056/NEJMra0910283

Musher, 2019, Acute Infection and Myocardial Infarction, N Engl J Med, 380, 171, 10.1056/NEJMra1808137

Giuseppe, 1995, Relation Between Diastolic Perfusion Time and Coronary Artery Stenosis During Stress-Induced Myocardial Ischemia, Circulation, 92, 342, 10.1161/01.CIR.92.3.342

Patel, 2016, Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure, Circ Res, 118, 1313, 10.1161/CIRCRESAHA.116.307708

Jiang, 2014, Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets, Nat Rev Cardiol, 11, 413, 10.1038/nrcardio.2014.59

Freeman, 1996, Angiotensin-(1-7) inhibits vascular smooth muscle cell growth, Hypertension, 28, 104, 10.1161/01.HYP.28.1.104

McCollum, 2012, Angiotensin-(1–7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts, Peptides, 34, 380, 10.1016/j.peptides.2012.01.020

Sampaio Walkyria, 2007, Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells, Hypertension, 50, 1093, 10.1161/HYPERTENSIONAHA.106.084848

Touyz, 2000, Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells, Pharmacol Rev, 52, 639

Alifano, 2020, Renin-angiotensin system at the heart of COVID-19 pandemic, Biochimie, 174, 30, 10.1016/j.biochi.2020.04.008

South, 2020, COVID-19, ACE2, and the cardiovascular consequences, Am J Physiol Heart Circ Physiol, 318, H1084, 10.1152/ajpheart.00217.2020

Guo, 2020, J Am Heart Assoc, 9, e016219, 10.1161/JAHA.120.016219

Chen, 2020, pokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19), medRxiv, 29

Shauer, 2013, Acute Viral Myocarditis: Current Concepts in Diagnosis and Treatment, Isr Med Assoc J, 15, 180

Caforio, 2013, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 2636, 10.1093/eurheartj/eht210

Nikolaou, 2018, Recurrent viral myocarditis: The emerging link toward dilated cardiomyopathy, Hellenic J Cardiol, 59, 60, 10.1016/j.hjc.2017.08.003

Kühl, 2005, Viral persistence in the myocardium is associated with progressive cardiac dysfunction, Circulation, 112, 1965, 10.1161/CIRCULATIONAHA.105.548156

Felker, 2000, Echocardiographic findings in fulminant and acute myocarditis, J Am Coll Cardiol, 36, 227, 10.1016/S0735-1097(00)00690-2

Ammirati, 2018, Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry, Circulation, 138, 1088, 10.1161/CIRCULATIONAHA.118.035319

Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128

Suffredini, 1989, The Cardiovascular Response of Normal Humans to the Administration of Endotoxin, N Engl J Med, 321, 280, 10.1056/NEJM198908033210503

Vieillard-Baron, 2014, Understanding cardiac failure in sepsis, Intensive Care Med, 40, 1560, 10.1007/s00134-014-3367-8

Badorff, 2004, Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside, Med Microbiol Immunol, 193, 121, 10.1007/s00430-003-0189-7

Kumar, 1996, Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, J Exp Med, 183, 949, 10.1084/jem.183.3.949

Atefi, 2011, Complement dependency of cardiomyocyte release of mediators during sepsis, Faseb J, 25, 2500, 10.1096/fj.11-183236

Fu, 2020, Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis, J Infect, 80, 656, 10.1016/j.jinf.2020.03.041

Cavusoglu, 2019, Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction, Hellenic J Cardiol, 60, 117, 10.1016/j.hjc.2018.03.006

Severino, 2012, Reversible atrial gap junction remodeling during hypoxia/reoxygenation and ischemia: a possible arrhythmogenic substrate for atrial fibrillation, Gen Physiol Biophys, 31, 439, 10.4149/gpb_2012_047

Goyal, 2020, Clinical Characteristics of Covid-19 in New York City, N Engl J Med, 382, 2372, 10.1056/NEJMc2010419

Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, 2020, 105949, 10.1016/j.ijantimicag.2020.105949

2020

Giudicessi, 2020, Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19), Mayo Clin Proc, 95, 1213, 10.1016/j.mayocp.2020.03.024

Verny, 1992, [Heart conduction disorders in long-term treatment with chloroquine. Two new cases], Presse Medicale Paris Fr, 21, 800

Shi, 2020, Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019, Eur Heart J, 41, 2070, 10.1093/eurheartj/ehaa408

Dong, 2011, Association between acute infections and risk of acute coronary syndrome: a meta-analysis, Int J Cardiol, 147, 479, 10.1016/j.ijcard.2011.01.035

Corrales-Medina, 2012, Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality, Circulation, 125, 773, 10.1161/CIRCULATIONAHA.111.040766

Puelles, 2020, Multiorgan and Renal Tropism of SARS-CoV-2, N Engl J Med, 10.1056/NEJMc2011400

Li, 2017, The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases, Pharmacol Res, 125, 21, 10.1016/j.phrs.2017.06.005

Nicin, 2020, Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts, Eur Heart J, 41, 1804, 10.1093/eurheartj/ehaa311

Lippi, 2020, Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19), Eur J Intern Med, 75, 107, 10.1016/j.ejim.2020.03.014

Vardavas, 2020, COVID-19 and smoking: A systematic review of the evidence, Tob Induc Dis, 20, 20

Wan, 2020, Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Gallagher T, J Virol, 94, e00127, 10.1128/JVI.00127-20

Oakes, 2018, Nicotine and the renin-angiotensin system, Am J Physiol Regul Integr Comp Physiol, 315, R895, 10.1152/ajpregu.00099.2018

Critchley, 2018, Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study, Diabetes Care, 41, 2127, 10.2337/dc18-0287

Wang, 2020, O-GlcNAc transferase promotes influenza A virus–induced cytokine storm by targeting interferon regulatory factor–5, Sci Adv, 6, 10.1126/sciadv.aaz7086

Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0

Romaní-Pérez, 2015, Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats, Endocrinology, 156, 3559, 10.1210/en.2014-1685

Tignanelli, 2020, Antihypertensive drugs and risk of COVID-19?, Lancet Respir Med, 8, e30, 10.1016/S2213-2600(20)30153-3

Reynolds, 2020, Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19, N Engl J Med, 382, 2441, 10.1056/NEJMoa2008975

Zhang, 2020, Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19, Circ Res, 126, 1671, 10.1161/CIRCRESAHA.120.317134

Esler, 2020, Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?, J Hypertens, 38, 781, 10.1097/HJH.0000000000002450

Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8

Patel, 2020, COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?, JAMA, 10.1001/jama.2020.4812

Danser, 2020, Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers, Hypertension, 75, 1382, 10.1161/HYPERTENSIONAHA.120.15082

2020

2020

Savarino, 2003, Effects of chloroquine on viral infections: an old drug against today's diseases, Lancet Infect Dis, 3, 722, 10.1016/S1473-3099(03)00806-5

Vincent, 2005, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol J, 2, 69, 10.1186/1743-422X-2-69

Magagnoli, 2020

Colson, 2020, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents, 55, 105932, 10.1016/j.ijantimicag.2020.105932

Molina, 2020, No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection, Med Mal Infect, 50, 384, 10.1016/j.medmal.2020.03.006

Mulangu, 2019, A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics, N Engl J Med, 381, 2293, 10.1056/NEJMoa1910993

Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0

Grein, 2020, Compassionate Use of Remdesivir for Patients with Severe Covid-19, N Engl J Med, 382, 2327, 10.1056/NEJMoa2007016

Liu, 2016, The cytokine storm of severe influenza and development of immunomodulatory therapy, Cell Mol Immunol, 13, 3, 10.1038/cmi.2015.74

Guo, 2020, Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis, Preprint at bioRxiv https://doi.org/10.1101/2020.04.08.029769 (2020)

Zimmermann, 2018, The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms, Front Immunol, 9, 302, 10.3389/fimmu.2018.00302

Ascierto, 2020, Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19, J Immunother Cancer, 8

Maude, 2014, Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies, Canc J, 20, 119, 10.1097/PPO.0000000000000035

Marques-da-Silva, 2011, Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action, Br J Pharmacol, 163, 912, 10.1111/j.1476-5381.2011.01254.x

Adler, 2015, The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases, Eur Heart J, 36, 2873, 10.1093/eurheartj/ehv318

Deftereos, 2020, The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design, Hellenic J Cardiol, S1109-9666(20)30061-0

Norman, 2020

Wang, 2020, Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China, Int J Environ Res Publ Health, 17, 1729, 10.3390/ijerph17051729

Owens, 2020, Reduced attendances and admissions: lessons from the covid crisis, Health Service Journal

Tam, 2020, Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China, Circ Cardiovasc Qual Outcomes, 13, 10.1161/CIRCOUTCOMES.120.006631

Moghadas, 2020, Projecting hospital utilization during the COVID-19 outbreaks in the United States, Proc Natl Acad Sci U S A., 117, 9122, 10.1073/pnas.2004064117

Iacobucci G. Covid-19: all non-urgent elective surgery is suspended for at least three months in England. BMJ. 020;368:m1106.

Koutsoukis, 2019, Challenges and unanswered questions in STEMI management, Hellenic J Cardiol, 60, 211, 10.1016/j.hjc.2019.01.001

Wu, 2020, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA, 10.1001/jama.2020.2648

Wang, 2020, Detection of SARS-CoV-2 in Different Types of Clinical Specimens, JAMA, 323, 1843

Guan, 2020, Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis, Eur Respir J, 55, 2000547, 10.1183/13993003.00547-2020

Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 10.1111/all.14238

Xu, 2020, Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2, Eur J Nucl Med Mol Imag, 47, 1275, 10.1007/s00259-020-04735-9

Arentz, 2020, Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State, JAMA, 323, 1612, 10.1001/jama.2020.4326

Mehra, 2020, Drug Therapy, and Mortality in Covid-19. N Engl J Med., 18382, e102

Lechien, 2020, Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019, J Intern Med, 10.1111/joim.13089

Wei, 2020, Acute myocardial injury is common in patients with covid-19 and impairs their prognosis, Heart, 10.1136/heartjnl-2020-317007

Richardson, 2020, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area, J Am Med Assoc, 323, 2052, 10.1001/jama.2020.6775

Gao, 2020, Prognostic value of NT-proBNP in patients with severe COVID-19, Respir Res, 21, 83, 10.1186/s12931-020-01352-w

Mo, 2020, Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China, Clin Infect Dis, 10.1093/cid/ciaa270

Liu, 2020, Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19, J Infect, 81, e6, 10.1016/j.jinf.2020.04.002

Xu, 2020, Mechanism of thrombocytopenia in COVID-19 patients, Ann Hematol, 99, 1205, 10.1007/s00277-020-04019-0

Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis, Clin Chim Acta Int J Clin Chem, 506, 145, 10.1016/j.cca.2020.03.022

American College of Cardiology, 2020

Han, 2020, CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic, Circulation, 141, e810, 10.1161/CIRCULATIONAHA.120.047011

Lakkireddy, 2020, Heart Rhythm

Skulstad, 2020, COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel, Eur Heart J Cardiovasc Imaging, 21, 592, 10.1093/ehjci/jeaa072